Forskolin  	Forskolin  	 NNP	B-NP
and  	and  	 CC	O
rutin  	rutin  	 RB	O
prevent  	prevent  	 VB	O
intraocular  	intraocular  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
spikes  	spikes  	 NN	I-NP
after  	after  	 IN	O
Nd 	Nd 	 NNP	B-NP
: 	: 	 :	O
YAG  	YAG  	 NNP	B-NP
laser  	laser  	 NN	I-NP
iridotomy  	iridotomy  	 VBD	O
the  	the  	 DT	O
purpose  	purpose  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
research  	research  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
whether  	whether  	 IN	O
an  	an  	 DT	O
oral  	oral  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
an  	an  	 DT	O
association  	association  	 NN	O
of  	of  	 IN	O
forskolin  	forskolin  	 NN	B-NP
and  	and  	 CC	O
rutin  	rutin  	 NNS	B-NP
can  	can  	 MD	O
blunt  	blunt  	 VB	O
the  	the  	 DT	O
intraocular  	intraocular  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
IOP 	IOP 	 NNP	B-NP
)  	)  	 -RRB-	O
spikes  	spikes  	 NN	O
and  	and  	 CC	O
avoid  	avoid  	 VB	O
the  	the  	 DT	O
damage  	damage  	 NN	O
that  	that  	 WDT	O
may  	may  	 MD	O
occur  	occur  	 VB	O
after  	after  	 IN	O
laser  	laser  	 NN	B-NP
iridotomy 	iridotomy 	 NN	I-NP
.  	.  	 .	O
Ten  	Ten  	 CD	O
patients  	patients  	 NNS	O
underwent  	underwent  	 VBD	O
bilateral  	bilateral  	 JJ	B-NP
Neodymium 	Neodymium 	 NNP	I-NP
: 	: 	 :	O
YAG  	YAG  	 NNP	B-NP
( 	( 	 -LRB-	O
Nd 	Nd 	 NNP	B-NP
: 	: 	 :	O
YAG 	YAG 	 NNP	B-NP
)  	)  	 -RRB-	O
laser  	laser  	 NN	B-NP
iridotomy  	iridotomy  	 NNS	I-NP
( 	( 	 -LRB-	O
Visulas  	Visulas  	 NNP	B-NP
YAG  	YAG  	 NNP	I-NP
III  	III  	 NNP	I-NP
Laser 	Laser 	 NNP	O
,  	,  	 ,	O
Zeiss 	Zeiss 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
for  	for  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
primary  	primary  	 JJ	B-NP
closed-angle  	closed-angle  	 JJ	I-NP
glaucoma 	glaucoma 	 NN	I-NP
.  	.  	 .	O
IOP  	IOP  	 NNP	B-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
in  	in  	 IN	O
subjects  	subjects  	 NNS	B-NP
before  	before  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
7  	7  	 CD	O
days  	days  	 NNS	O
of  	of  	 IN	O
pretreatment  	pretreatment  	 NN	B-NP
with  	with  	 IN	O
placebo  	placebo  	 NN	O
or  	or  	 CC	O
forskolin  	forskolin  	 NNS	B-NP
and  	and  	 CC	O
rutin  	rutin  	 NN	B-NP
by  	by  	 IN	O
Goldman  	Goldman  	 NNP	B-NP
applanation  	applanation  	 FW	I-NP
tonometry 	tonometry 	 FW	I-NP
.  	.  	 .	O
The  	The  	 DT	O
IOP  	IOP  	 NNP	B-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
before  	before  	 IN	O
surgery  	surgery  	 NN	O
and  	and  	 CC	O
after  	after  	 IN	O
surgery  	surgery  	 NN	O
at  	at  	 IN	O
30-60-120  	30-60-120  	 CD	O
minutes 	minutes 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
4-7  	4-7  	 CD	O
days 	days 	 NNS	O
.  	.  	 .	O
Analysis  	Analysis  	 NN	O
of  	of  	 IN	O
variance  	variance  	 NN	O
indicated  	indicated  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
postoperative  	postoperative  	 JJ	B-NP
values  	values  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
receiving  	receiving  	 VBG	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
placebo  	placebo  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 FW	O
< 	< 	 SYM	O
0.001 	0.001 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
in  	in  	 IN	O
those  	those  	 DT	O
who  	who  	 WP	O
received  	received  	 VBD	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
forskolin  	forskolin  	 NN	B-NP
and  	and  	 CC	O
rutin  	rutin  	 JJ	B-NP
association 	association 	 NN	I-NP
.  	.  	 .	O
T  	T  	 NN	B-NP
test  	test  	 NN	I-NP
analysis  	analysis  	 NN	I-NP
confirmed  	confirmed  	 VBD	O
that  	that  	 IN	O
IOP  	IOP  	 NNP	B-NP
still  	still  	 RB	O
remained  	remained  	 VBD	O
significantly  	significantly  	 RB	O
elevated  	elevated  	 VBD	O
7  	7  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
laser  	laser  	 NN	O
intervention  	intervention  	 NN	O
in  	in  	 IN	O
placebo  	placebo  	 JJ	O
treated  	treated  	 JJ	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
whereas  	whereas  	 IN	O
it  	it  	 PRP	O
stayed  	stayed  	 VBD	O
within  	within  	 IN	O
normal  	normal  	 JJ	B-NP
values  	values  	 NNS	I-NP
in  	in  	 IN	O
forskolin 	forskolin 	 CD	B-NP
/ 	/ 	 CD	I-NP
rutin  	rutin  	 NNS	I-NP
treated  	treated  	 VBN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Forskolin  	Forskolin  	 NNP	B-NP
and  	and  	 CC	O
rutin  	rutin  	 NNS	B-NP
can  	can  	 MD	O
blunt  	blunt  	 VB	O
the  	the  	 DT	O
increase  	increase  	 NN	O
of  	of  	 IN	O
IOP  	IOP  	 NNP	B-NP
that  	that  	 WDT	O
occurs  	occurs  	 VBZ	O
after  	after  	 IN	O
Nd-YAG  	Nd-YAG  	 JJ	B-NP
laser  	laser  	 NN	I-NP
iridotomy 	iridotomy 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
can  	can  	 MD	O
avoid  	avoid  	 VB	O
serious  	serious  	 JJ	B-NP
risk  	risk  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
optic  	optic  	 JJ	B-NP
nerve  	nerve  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
under  	under  	 IN	O
laser  	laser  	 NN	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
iridotomy 	iridotomy 	 NN	B-NP
.  	.  	 .	O
